It’s not enough to be researchers. We are pioneers.

Steve had worked with Dupont during his graduate school years, and the company was eager to hire him when he finished his PhD program. He spent several years as a research chemist at the Central Experimental Station in Delaware developing analytical methods for controlling active ingredients and impurities in crop protection products. His next job as Senior Algorithm Scientist with MediSpectra, was more personally fulfilling for Steve, because he was developing predictive models for an optically-based system that detected cervical cancer cells. Unfortunately, the FDA recommended against market approval, the investors pulled out, and Steve was out of a job. Fortunately, on his last day of work, Infraredx came calling.

Even after 14 years at Infraredx, Steve feels there’s always something new to learn. He began his tenure as Senior Scientist, moving on to Principal Scientist of Algorithm Development, then Director of Biomedical Systems and then Vice President of Research and Development. In his current position as Senior Vice President of Technology Innovation and Regulatory Affairs, Steve maintains strong relationships with opinion leaders in cardiology to understand where some of their less obvious challenges are. He takes that intelligence and applies it to each new iteration of Infraredx devices to ensure alignment with customer needs as well as regulatory requirements.

Over the years, Steve’s passion for developing new and improved ways to detect and evaluate vascular disease has never waned. “Being able to come in to work each day, to learn what MDs need to better identify patients with a high risk of cardiovascular disease, and to help define new standards of care ⎯ that’s what really gets me out of bed every morning.”

We all have the potential to push the boundaries of what is accepted, or expected, and to think big. - Stephen Hawking